State Street Corp Exact Sciences Corp Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, State Street Corp holds 6,680,188 shares of EXAS stock, worth $375 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,680,188

Previous 8,210,058 18.63%

Holding current value

$375 Million

Previous $347 Million 31.13%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$42.43 - $70.83 $64.9 Million - $108 Million	-1,529,870 Reduced 18.63%	6,680,188 $455 Million
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $129 Million - $231 Million	3,116,411 Added 61.18%	8,210,058 $347 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $4.1 Million - $5.38 Million	72,905 Added 1.45%	5,093,647 $352 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $30.1 Million - $38.6 Million	510,139 Added 11.31%	5,020,742 $371 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $9.02 Million - $13.5 Million	136,796 Added 3.13%	4,510,603 $308 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $11.5 Million - $17.5 Million	-183,710 Reduced 4.03%	4,373,807 $411 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $29.3 Million - $44 Million	-621,286 Reduced 12.0%	4,557,517 $309 Million
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $4.61 Million - $8.08 Million	-151,946 Reduced 2.85%	5,178,803 $256 Million
Q3 2022 Nov 15, 2022	BUY	$31.97 - $49.37 $3.65 Million - $5.63 Million	114,054 Added 2.19%	5,330,749 $173 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $25.6 Million - $54.8 Million	718,536 Added 15.97%	5,216,695 $205 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $14.2 Million - $20.4 Million	247,246 Added 5.82%	4,498,159 $315 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $13.2 Million - $18.3 Million	181,599 Added 4.46%	4,250,913 $331 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $17.7 Million - $24.4 Million	196,624 Added 5.08%	4,069,314 $388 Million
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $49.8 Million - $74.1 Million	532,211 Added 15.93%	3,872,690 $481 Million
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $14.2 Million - $18.9 Million	-121,659 Reduced 3.51%	3,340,479 $440 Million
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $15.6 Million - $22.3 Million	-156,674 Reduced 4.33%	3,462,138 $459 Million
Q3 2020 Nov 10, 2020	BUY	$72.92 - $102.01 $667,145 - $933,289	9,149 Added 0.25%	3,618,812 $369 Million
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $12.9 Million - $21.4 Million	-231,127 Reduced 6.02%	3,609,663 $314 Million
Q1 2020 May 11, 2020	BUY	$37.9 - $104.44 $146 Million - $401 Million	3,840,790 New	3,840,790 $223 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.93B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Exact Sciences Corp Transaction History